We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT (CARTOAF&VT)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2009 by Korea University.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT00959205
First Posted: August 14, 2009
Last Update Posted: May 20, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Korea University
August 13, 2009
August 14, 2009
May 20, 2010
July 2009
June 2010   (Final data collection date for primary outcome measure)
  • Fluoroscopic time [ Time Frame: 24weeks ]
    Total duration of procedure using fluoroscopy on , in minute
  • Procedural duration [ Time Frame: 24weeks ]
    Time from after puncture to catheter remover
Not Provided
Complete list of historical versions of study NCT00959205 on ClinicalTrials.gov Archive Site
  • Ablation time [ Time Frame: 24weeks ]
    Time from to Ablation
  • Procedural Success [ Time Frame: 24weeks ]
    Achievement of the procedure endpoint for each arrhythmia
  • Clinical Success [ Time Frame: 24weeks ]
    • 3 months freedom from recurrence of target arrhythmia
    • > 6 months freedom from recurrence of target arrhythmia
  • Radiation dose [ Time Frame: 24weeks ]
    Calculated dose (in Gray) to the patient as recorded in the laboratory log
  • Morphology of ablation [ Time Frame: 24weeks ]
    Number of Gap and the distance from the ostia of the pulmonary veins (In conventional group)
  • Complications [ Time Frame: 24weeks ]
    • procedure and device related adverse event requiring any intervention to prevent permanent medical intervention
    • Important complications are reported individually
  • Cost Effectiveness [ Time Frame: 24weeks ]
  • Survival Rate [ Time Frame: 24weeks ]
Not Provided
Not Provided
Not Provided
 
The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT
Phase Ⅳ Study of CARTO 3D Mapping System vs Conventional Method in AF & VT
The purpose of this study is to evaluate the efficacy and safety of electroanatomic imaging compared to conventional method in patients with VT.
To evaluate the efficacy and safety of electroanatomic imaging (CARTO) compared to conventional fluoroscopically guided activation mapping (Conventional) method in patients with Atrial Fibrillation and Substrate-dependent Ventricular Tachycardia To evaluate cost-effectiveness of CARTO 3D image system compared to conventional method in the same study subjects
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Atrial Fibrillation
  • Device: CARTO 3D
    CARTO (3D Electroanatomic imaging)
  • Device: Angiography
    Conventional fluoroscopically guided activation mapping
    Other Name: Celsius
  • Active Comparator: Angiography
    Conventional fluoroscopically guided activation mapping
    Intervention: Device: Angiography
  • Experimental: CARTO 3D
    CARTO (3D Electroanatomic imaging)
    Intervention: Device: CARTO 3D
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
160
February 2011
June 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with AF or substrate-dependent VT

Exclusion Criteria:

  • administering with anticoagulants
Sexes Eligible for Study: All
20 Years to 85 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00959205
2009_KU_CARTO
Yes
Not Provided
Not Provided
Young-Hoon Kim, Korea medical center
Korea University
Not Provided
Principal Investigator: Kim Young-Hoon, MD, PhD Korea medical center
Korea University
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP